Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Jansen (Seattle, United States of America), T. Gould (Seattle, United States of America), J. Stewart (Seattle, United States of America), M. Young (Seattle, United States of America), P. Janssen (Seattle, United States of America), Z. Afsharinejad (Seattle, United States of America), C. Sack (Seattle, United States of America), T. Larson (Seattle, United States of America), S. Vedal (Seattle, United States of America), J. Kaufman (Seattle, United States of America). Changes in hematologic indices and inflammatory markers in a double-blind real world traffic exposure study. 1194

Member's Comments

No comment yet.

Related content which might interest you: Do marker states improve measurement properties of utility instruments: a randomized multi-center trial in patients with chronic respiratory disease Source: Eur Respir J 2004; 24: Suppl. 48, 295s Year: 2004 Ozone exposure leads to changes in airway permeability, microbiota and metabolome: a randomised, double-blind, crossover trial Source: Eur Respir J, 56 (3) 2000165; 10.1183/13993003.00165-2020 Year: 2020 Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials Source: Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020 Year: 2021 Progression of physical inactivity in COPD patients: the effect of time and climate conditions – a multicentre prospective cohort study Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019 A randomized double-blind study of specific immunotherapy (SIT) in patients with seasonal allergic rhinitis: effects on clinical and inflammatory markers Source: Eur Respir J 2001; 18: Suppl. 33, 482s Year: 2001 Mandibular advancement therapy does not reduce inflammatory and metabolic biomarkers in patients with severe OSA: a randomized controlled trial Source: International Congress 2018 – Upper airways morphology and diagnostics, and the challenges associated with mandibular advancement Year: 2018 Predictors for detecting chronic respiratory diseases in population surveys: a pilot study for RESPIRE 4CCORD study Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases Year: 2021 Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year. Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 Rates of major cardiovascular events in severe asthma: US real-world and clinical trial populations Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Changes in pulmonary function and patient-reported outcomes during COVID-19 recovery: a longitudinal, prospective cohort study Source: ERJ Open Res, 7 (3) 00243-2021; 10.1183/23120541.00243-2021 Year: 2021 Evaluation of factors to consider prior to adjustment of biologic quality control ranges using data from a large multi-centre clinical trial Source: Annual Congress 2009 - Quality control in lung function and new developments Year: 2009 The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma Source: Eur Respir J 2003; 22: 470-477 Year: 2003 A real life multicenter national study on the use of nintedanib in moderate to severe IPF patients Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Impact of different intensities of resistance training on health status focusing on activities of daily living in patients with COPD: randomized controlled study Source: International Congress 2019 – Insights into rehabilitation and physical activity of patients with respiratory disease Year: 2019 Randomised controlled, crossover trial to evaluate the effects of ambulatory oxygen on health status in patients with fibrotic lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007 Markers of neutrophil extracellular traps predict adverse outcome in community-acquired pneumonia: secondary analysis of a randomised controlled trial Source: Eur Respir J, 51 (4) 1701389; 10.1183/13993003.01389-2017 Year: 2018 A multicentre cohort study on the association between common markers of asthma and the incidence of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 295s Year: 2006 The association of the oxygen saturation level at the time of hospitalization with comorbidities and subsequent changes in blood biomarkers in patients with COVID-19 in Russia: observational study results. Source: Virtual Congress 2021 – COVID - 19: lessons learned Year: 2021 Can extended hematological parameters of inflammation predict the severity and outcome of AECOPD? Source: Virtual Congress 2020 – COPD phenotypes Year: 2020